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
The impact of the three most common apolipoprotein E (APOE) genotypes (ε32, ε33, and ε43) on
means, variances, and correlations of nine plasma lipid and apolipoprotein traits (total cholesterol,
lnTriglycerides, HDL cholesterol, and apolipoproteins AI, AII, B, CII, CIII, and lnE) was studied
in 212 unrelated female and 219 unrelated male children aged 5–21.5 years from 278 pedigrees
ascertained without regard to health status from Rochester, Minnesota. There was significant
heterogeneity (p% 0.05) among genotypes for the mean plasma levels of lnApo E, Apo CII, Apo
CIII, and lnTriglycerides (lnTrig) in females, and for the means of lnApo E, Apo B, and total
cholesterol (Total-C) in males. Significant heterogeneity of intragenotypic variance was observed in
males for Apo CII, lnTrig, and HDL-C; no significant heterogeneity was observed in females.
Pairwise correlations between traits differed significantly among APOE genotypes in both females (6
of 36 pairs) and males (5 of 36 pairs). These results differ from those obtained from studies of the
parental generation from the same sample of pedigrees. Our study further demonstrates that, with
the exception of mean lnApo E levels, the univariate and bivariate distributions of traits that are
measures of lipoprotein metabolism are influenced by variation in the APOE gene in a gender- and
generation-dependent manner.

Coronary heart disease (CHD, defined by a
history of myocardial infarction and}or angina
pectoris) affects 14 million individuals in the
United States and was the primary cause of
approximately half a million deaths in 1995
(AHA, 1998). CHD is the clinical manifestation
of a lifelong disease process that begins in
childhood, with the early stages characterized by
lipid deposition and build-up in the walls of the
coronary arteries at sites of intimal injury
(PDAY, 1990; Ross, 1993; McGill et al. 1997). A
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number of studies of CHD risk factors in youth
have been initiated to better understand the
early natural history of the disease process
(Lauer et al. 1975; Berenson et al. 1980; PDAY,
1990; Akerblom et al. 1991). The goals of such
research are to identify risk factor patterns that
characterize children at increased risk of mani-
festing CHD in adulthood and to develop disease
intervention strategies for those children.
Variation in most CHD risk factors is
influenced by genetic variation (Sing & Skolnick,
1979; Rao et al. 1984). Knowledge about the
influence of genetic variation on variation in risk
of CHD could provide more reliable methods for
early detection of disease, provide insights into
the etiology of CHD, and aid in the rational
development of prevention and treatment
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strategies. However, identifying and evaluating
the genetic variations that contribute to CHD
risk in the population at large is complicated by
the fact that the manifestations of disease
aggregate in families, but do not segregate in
accordance with Mendelian expectations. In
other words, the statistical relationships between
variations in any particular gene and the pres-
ence or absence of disease are not one-to-one
(Badimon et al. 1993; Sing et al. 1996). Conse-
quently, estimation of the statistical association
of interindividual variation in established CHD
risk factors with variation in candidate genes has
become a widely used approach to estimating the
relative contribution of measured genetic
variations to variation in risk of CHD. This
approach is used here to evaluate the con-
tribution of the common genotypic variations in
the gene (APOE) coding for the apolipoprotein E
protein (Apo E) to predicting interindividual
variation in quantitative levels of nine plasma
lipid and apolipoprotein traits. The APOE gene
has received considerable attention as a CHD
susceptibility factor because of the involvement
of its protein product in lipid metabolism and its
association with CHD risk (see Davignon et al.
1988 and Mahley, 1988 for reviews). Many studies
have established that interindividual variation
in levels of various plasma lipid and apolipo-
protein traits (Sing & Davignon, 1985; Davignon
et al. 1988; Hallman et al. 1991; Kaprio et al.
1991; Xhignesse et al. 1991) as well as prevalence
(reviewed in Davignon, 1993) and incidence
(Stenga/ rd et al. 1995) of CHD are associated with
variation in the APOE gene.
Nearly all studies that investigate the influence
of genetic variability on interindividual variation
in measures of cardiovascular health and disease
focus on differences among genotype-specific
trait means. Although, from a public health
perspective, it is straightforward to assess geno-
typic information in terms of variation in average
quantitative risk factor levels (Grundy et al.
1998), restricting attention to the genotypic
means does not capture genotype specific
influences on variation in risk factor levels among
individuals within genotypic classes. Most
studies of genotypic effects assume homogeneity
of the intragenotypic variability and co-varia-
bility of traits among individuals across geno-
typic stratifications of the population. In this
study we investigate the influences of the
common APOE genotypes on intragenotypic
variances and intragenotypic bivariate relation-
ships of nine traits that are measures of lipo-
protein metabolism, as well as their influence on
the average level of each of these traits.
Lipid metabolism displays many properties
characteristic of a complex system (Bar-Yam,
1997): (1) it consists of many agents that are
organized hierarchically (e.g. genes that code for
regulatory, structural, and enzymatic proteins
influence protein products, plasma lipoproteins
and lipids, and cellular and tissue physiology and
morphology); (2) there is interaction between
agents (e.g. formation of lipoprotein particles,
lipolysis, and receptor-mediated endocytosis) ;
(3) there is variability in the quality and quantity
of the agents (e.g. variation in LDL subtype
concentrations) ; (4) the system responds to
variation in its environment (e.g. post-prandial
lipemia) ; and (5) together the agents function in
a non-linear fashion in the process of regulation,
transport, and metabolism of lipids to produce
the observed risk factor phenotype. Variability
in CHD risk cannot be solely ascribed to
variation in any particular agent. Furthermore,
because the relationships among agents in a
complex system like lipid metabolism can
influence the risk of CHD (Ferrannini, 1991;
Austin, 1992; Sing & Reilly, 1993; Reilly et al.
1994), understanding the influence of genetic
variation on interindividual variation of a par-
ticular agent may not be as important as
understanding its influence on interindividual
variation in the relationships between the agents
(Bailey, 1999).
We demonstrate in this paper that the
influence of variation in the APOE gene on the
means, variances, and correlations of plasma
lipids and apolipoproteins is characterized by a
combination of invariant and context (as defined
by gender and generation) dependent genotype
effects.
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Sample
As part of the first phase of the Rochester
Family Heart Study (RFHS), 281 three gen-
eration pedigrees were ascertained without re-
gard to health status through elementary school
children in Rochester, MN. Details of the
methods for ascertainment are described else-
where (Moll et al. 1989; Turner et al. 1989). In
these pedigrees, there were 415 females and 434
males ranging from 5 to 35 years of age in the
child generation. To reduce the contribution of
age to variation in lipid metabolism, we removed
89 individuals who were older than 21.5 years of
age. Furthermore, children who did not possess
one of the three most common APOE genotypes
(ε32, ε33, and ε43), or had missing values for any
of the traits considered in this study, were
removed from the sample. We also removed from
the study children with one or more measure-
ments of plasma lipids and apolipoproteins
greater than four standard deviations from their
APOE genotype-specific means. This resulted in
the removal of one ε32 female, five ε33 females
and one ε33 male from further consideration.
Finally, to remove the confounding effects of
genetic relatedness and shared environment on
the variation in the traits considered here, one
child of each gender was randomly selected from
each pedigree for inclusion in our study. The final
sample consisted of 212 females (22 ε32, 136 ε33,
and 54 ε43) and 219 males (33 ε32, 123 ε33, and
63 ε43) from 278 pedigrees.
Laboratory methods
Blood samples were collected by venipuncture
in EDTA after the subjects had fasted overnight.
Plasma apolipoprotein (Apo) AI, AII, CII, CIII,
and E levels were measured in multiple replicates
by radioimmunoassay (Kottke et al. 1991). Apo
B was measured by enzyme-linked immuno-
sorbent assay (Kottke et al. 1991). Plasma total
cholesterol (Total-C) and triglycerides (Trig)
levels were measured by standard enzymatic
methods (Barham & Trinder, 1972; Barr et al.
1981). High density lipoprotein cholesterol
(HDL-C) was measured after precipitation of
Apo B containing lipoproteins with polyethelene
glycol (Izzo et al. 1981). The APOE genotypes
were inferred from isozyme phenotypes
(Weisgraber et al. 1981; Mailly et al. 1992)
determined by isoelectric focusing plasma
samples on polyacrylamide gels, followed by
immunoblotting with human Apo E antiserum,
as described by Kamboh et al. (1988).
Statistical methods
Because the natural history of CHD is gender
dependent (Barrett-Conner, 1997), all analyses
were carried out separately in females and males.
For the test of homogeneity of the lipid and
apolipoprotein means, variances, or correlations
among the most common APOE genotypes we
considered two null hypotheses, ε32¯ ε33 and
ε43¯ ε33, which focus our attention on the
differences among individuals with the less
common heterozygous genotypes (ε32 and ε43)
and individuals with the most common homo-
zygous ε33 genotype. Throughout this report, we
use a p-value of less than 0.05 as our criterion for
statistical significance; however, we also report
the probability corresponding to each test stat-
istic to enable the readers to apply their own
criterion of statistical significance.
To test the equality of genotype-specific
means, we used Student’s t-test unless there was
evidence of significant heterogeneity of variance,
which was assessed using the F-ratio test (Neter
et al. 1990). When the null hypothesis of
homoscedasticity was rejected, Satterthwaite’s
approximate t-test – which is robust to hetero-
geneity of interindividual variances – was used
in place of Student’s t-test (Satterthwaite, 1946).
Intragenotypic pairwise correlations between all
pairs of plasma lipid and apolipoprotein traits
were estimated by Pearson’s product moment
correlation coefficient. The test of homogeneity
of a particular pairwise correlation between two
genotype classes was carried out using a chi-
squared test on transformed correlation
coefficients as described by Sokal & Rohlf (1981).
The total correlation, computed as the sum of
the absolute values of pairwise correlations, was
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used to summarize the complex patterns of
correlation observed for each APOE genotype
class and to provide a measure of cohesiveness
among the nine interrelated and interacting
traits of lipid metabolism (Reilly et al. 1994).
Because the distribution of the total correlation
statistic is unknown, we tested the null hy-
pothesis of homogeneity of total correlations
between APOE genotypes using the bootstrap
method (Efron & Tibshirani, 1993). To carry out
these tests, 1000 bootstrap samples were created
by randomly sampling with replacement from
the original sample. The APOE genotype
frequencies in each bootstrap sample were con-
strained to be the same as in the original sample
(see sample description above). For each boot-
strap sample the genotype-specific total corre-
lations were estimated and the differences in the
total correlation between the ε33 and the ε32 or
the ε43 were computed. Quantiles from the
empirical distribution of the 1000 bootstrap
estimates of the difference in total correlation
produced approximate 95% and 99% confidence
intervals about the original sample estimate. If
the resulting confidence intervals did not include
zero the null hypothesis of homogeneity of total
correlations was rejected with p% 0.05 and
p% 0.01, respectively.
The validity of the parametric tests of hom-
ogeneity of means, variances, and pairwise
correlations among genotypes used here relies on
the assumption that the genotype-specific dis-
tribution of each trait is approximately normal.
After adjusting all plasma lipid and apolipo-
protein values for variation due to date of assay,
we assessed the resulting genotype-specific distri-
butions for normality with the Shapiro–Wilk test
statistic (Shapiro & Wilk, 1965). Most of the
traits, except Apo E and Trig, did not deviate
significantly from normality for at least five of
the six gender-genotype strata. We chose not to
transform these deviant gender-genotype distri-
butions for reasons of comparability between
genotypes. Plasma Apo E and Trig showed the
greatest deviations from normality. In five of the
six genotype-gender strata the null hypothesis of
normality was rejected for both traits. The
distributions of plasma Apo E and Trig were
generally skewed (0.5! g
"
! 4.0) and leptokurtic
(0.3! g
#
! 23.9). A natural logarithm trans-
formation applied to Apo E and Trig reduced





! 6.0). All analyses were per-
formed on the natural logarithm transformed
values of Apo E and Trig, which we denote lnApo
E and lnTrig.

The descriptive statistics for the concomitants
age, height, weight, body mass index (BMI), and
waist to hip ratio (WHR), and plasma levels of
lnApo E, Apo CII, Apo CIII, lnTrig, Apo AI,
Apo AII, HDL-C, Apo B, and Total-C are given
in Table 1 by gender. Females were not signifi-
cantly different from males for either average age
or variability in age. However, on average, males
were significantly taller, heavier, and had a
greater WHR than females. Of the plasma lipid
and apolipoprotein means, only Apo CII differed
significantly between genders, with females
having lower average plasma levels than males.
Males showed significantly greater inter-
individual variation in height, Apo CII, and
Total-C, and significantly less variation in WHR.
The average age, height, weight, BMI, and WHR
did not differ significantly among APOE geno-
types in females or in males (analyses not shown).
Influence of APOE genotype variation in children
The plasma lipid and apolipoprotein means
and variances, stratified by gender and APOE
genotype, are given in Tables 2 and 3 for females
and males, respectively. In females, mean levels
of lnApo E, Apo CII, Apo CIII, and lnTrig were
significantly greater in ε32 children than in those
with the ε33 genotype. The mean level of lnApo
E in ε43 females was significantly lower and the
mean level of lnTrig was significantly higher
than for ε33 females. In males, the mean level of
lnApo E in ε32 children was significantly greater
and the mean level of Total-C was significantly
lower than for those with the ε33 genotype. The
ε43 males had a significantly lower mean lnApo
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Table 1. Summary statistics for concomitants, plasma lipids, and apolipoproteins by gender
Females Males p-Values
n¯ 212 n¯ 219 t-test† F-test
Trait Means Variances Means Variances Means Variances
Concomitants
Age (yr) 13.9 15.9 13.8 13.7 0.729 0.286
Height (cm) 154.9 256.1 159.8 340.1 0.004 0.039
Weight (kg) 49.4 257.2 52.8 319.4 0.038 0.114
BMI (kg}cm#¬1000) 2.0 0.14 2.0 0.12 0.972 0.159
WHR 0.80 0.004 0.83 0.002 ! 0.001 ! 0.001
Plasma Traits (mg}dl)
lnApo E 1.4 0.16 1.4 0.17 0.214 0.610
Apo CII 1.8 0.28 2.0 0.37 ! 0.001 0.041
Apo CIII 12.2 9.9 12.5 9.45 0.482 0.711
lnTrig 4.4 0.13 4.4 0.14 0.320 0.293
Apo AI 129.0 296.1 127.6 256.9 0.380 0.299
Apo AII 32.9 18.5 32.5 23.5 0.464 0.081
HDL-C 47.8 104.8 46.3 113.8 0.131 0.546
Apo B 66.9 108.4 65.9 89.5 0.334 0.161
Total-C 149.5 576.3 149.7 754.5 0.929 0.049
† If the variances were found to be significantly different (p% 0.05) by the F-test, then Satterthwaite‘s approximate
t-test was used.
Table 2. Means and variances of plasma










ε32¯ ε33 ε33¯ ε43
Means (mg}dl)
lnApo E 1.7 1.5 1.2 0.009 ! 0.001
Apo CII 2.2 1.8 1.8 0.002 0.758
Apo CIII 14.4 11.9 12.2 0.001 0.633
lnTrig 4.6 4.4 4.5 0.002 0.046
Apo AI 130.0 128.8 129.2 0.743 0.892
Apo AII 33.2 32.5 33.6 0.497 0.135
HDL-C 49.3 48.2 46.2 0.647 0.232
Apo B 66.6 66.3 68.2 0.913 0.260
Total-C 145.4 148.9 152.7 0.436 0.333
Variances
lnApo E 0.2 0.1 0.1 0.123 0.121
Apo CII 0.2 0.3 0.3 0.949 0.257
Apo CIII 9.7 9.5 9.3 0.894 0.940
lnTrig 0.1 0.1 0.1 0.746 0.741
Apo AI 167.9 284.6 186.6 0.164 0.164
Apo AII 17.6 18.1 19.8 0.999 0.662
HDL-C 124.5 109.3 85.6 0.632 0.312
Apo B 118.6 116.2 86.0 0.887 0.213
Total-C 327.8 611.7 587.7 0.098 0.888
† If the variances were found to be significantly different
(p% 0.05) by the F-test, then Satterthwaite‘s approxi-
mate t-test was used.
E and significantly higher mean Apo B levels
than ε33 males.
In contrast to the results of comparisons of
plasma lipid and apolipoprotein means between
genotypes, significant heterogeneity of the intra-
genotypic interindividual variances among
genotypes was observed only in males for three
traits. Interindividual variability in lnTrig and
Apo CII was significantly greater among ε32
males than among males with the ε33 genotype.
The interindividual variance of HDL-C was
significantly smaller among ε43 males than
among males with the ε33 genotype.
Estimates of the 36 pairwise correlations
among the nine lipid and apolipoprotein traits
for each APOE genotype were computed and the
tests of significance were carried out. Figures 1A
and 2A offer a graphical representation of those
pairwise correlations that have an absolute
value, r r r, that exceeds 0.3 in females and males,
respectively. We chose to display only those
correlations with values greater than 0.3 (i.e. r#"
0.09, where r# can be loosely interpreted as the
amount of variation in one trait that is explained
by a second trait) to focus attention on those
pairwise associations of greater biological rel-
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Table 3. Means and variances of plasma










ε32¯ ε33 ε33¯ ε43
Means (mg}dl)
lnApo E 1.6 1.4 1.1 0.007 ! 0.001
Apo CII 2.1 2.0 2.1 0.495 0.448
Apo CIII 12.5 12.3 12.7 0.753 0.453
lnTrig 4.5 4.4 4.5 0.184 0.330
Apo AI 123.6 128.2 128.4 0.153 0.944
Apo AII 31.4 32.4 33.5 0.280 0.148
HDL-C 45.1 47.0 45.6 0.318 0.394
Apo B 63.5 65.4 68.3 0.316 0.043
Total-C 136.9 150.3 155.3 0.012 0.242
Variances
lnApo E 0.1 0.2 0.1 0.712 0.902
Apo CII 0.7 0.3 0.3 0.008 0.366
Apo CIII 9.7 10.3 7.8 0.877 0.217
lnTrig 0.2 0.1 0.2 0.017 0.332
Apo AI 239.7 278.1 222.2 0.642 0.328
Apo AII 24.3 22.1 25.0 0.690 0.549
HDL-C 79.9 141.4 78.6 0.063 0.011
Apo B 86.1 82.9 97.8 0.847 0.436
Total-C 554.4 770.7 730.9 0.282 0.830
† If the variances were found to be significantly different
(p% 0.05) by the F-test, then Satterthwaite’s approxi-
mate t-test was used.
evance (statistically significant correlations as
small as r¯ 0.18, i.e. r#¯ 0.03, were observed).
The magnitude of each correlation coefficient is
represented by the thickness of the line con-
necting two traits. The sign of the correlation is
represented by the line type; solid lines indicate
positive correlations and broken lines indicate
negative correlations. The results of the tests of
the equality of the Pearson product-moment
correlation coefficients between the ε33 and the
ε32 or the ε43 genotypes are presented in Figures
1B and 2B. These figures display all statistically
significant differences between genotype-specific
correlation coefficients (ε33–ε32 and ε33–ε43) for
females and males, respectively.
The patterns of pairwise correlation (Figures
1A and 2A) suggests that some relationships
between traits are common to most gender-
genotype strata and some are specific to a single
stratum. In females (Figure 1A) the strongest
relationships conserved across genotypes (r r r&
0.45) were between Apo CII:Apo CIII and
between Apo B:Total-C. Examination of the
difference correlation plots in Figure 1B indicates
that the correlations between Apo AI:HDL-C
and between lnApo E:Apo B were significantly
greater in ε33 than in ε32 females. The pairwise
correlations between lnApo E:Apo AI, Apo
CII:Apo B, Apo AI:Apo B, and Apo AII:Apo B
were significantly greater in ε43 than in ε33
females.
Figure 2A shows the genotype-specific
patterns of correlation in males. There were
multiple correlations with r r r& 0.45 within all
three APOE genotypes: Apo CII:Apo CIII, Apo
AI:HDL-C, Apo AI:Apo AII, and Apo B:Total-
C. In contrast to females, more significant
pairwise heterogeneity was observed between ε32
and ε33 males. The difference correlation plots
shown in Figure 2B indicate that ε33 males had
significantly greater correlations between Apo
AI:HDL-C and between Apo AI:Total-C and
significantly lower correlations between lnApo
E:Total-C and between Apo CII:Apo CIII than
ε32 males. Also, the correlation between Apo
B:lnTrig was significantly greater in ε43 than ε33
males. We note that the correlation between Apo
AI:HDL-C was significantly greater in ε33 than
ε32 in both females and males.
To aid in summarizing the complex patterns of
correlation observed within each APOE genotype
and to provide a summary measure of the
cohesiveness among these nine interrelated and
interacting components of the lipid metabolic
pathway we employed the total correlation (TC)
statistic suggested by Reilly et al. (1994). In
females, the total correlations for the ε32, ε33,
and ε43 genotypes were 10.83, 10.10, and 14.16,
respectively. The total correlation for the ε43
genotype was significantly greater than the
reference ε33 genotype (p% 0.05). In males, the
total correlations for the ε32, ε33, and ε43
genotypes were 11.42, 11.33, and 12.26, respect-
ively. The differences between these estimates of
total correlation were not statistically significant
(p" 0.05).
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Fig. 1. (A) Correlation diagrams showing the bivariate correlations between traits where r r r" 0.3 for each
APOE genotype in females. TC is the sum of the 36 pairwise correlations. (B) Difference correlation diagrams
showing the statistically significant differences between genotype-specific bivariate correlations.
Comparison of the influence of APOE genotype
in children and parents
Analyses of the influence of APOE genotype on
means, variances, and correlations similar to
those reported in this paper were conducted
previously on a sample from the parental gen-
eration (ages 26–64) from the same sample of
pedigrees from Rochester, MN (Reilly et al. 1991;
1994). Rather than carry out a statistical
comparison of the genotype-specific plasma lipid
and apolipoproteins in children and parents, we
offer a qualitative comparison of the generation-
specific phenotypic response to variation in
APOE genotype. The results of the tests of
homogeneity of means, variances, and corre-
lations in the children and parents are sum-
marized in Figure 3.
First, we compared the influence of variation
in the APOE gene on the trait means in each
generation. As shown in Figure 3 (first column),
of the nine lipid and apolipoprotein traits studied
in parents and children, only the mean trans-
formed levels of the protein product of the APOE
gene itself, lnApo E, differed significantly among
APOE genotypes in both genders and
generations. In all four gender- and generation-
specific strata, significantly higher levels of
lnApo E were associated with the ε32 genotype
and significantly lower levels were associated
with the ε43 genotype. For females only, the Apo
CIII means were significantly higher in indi-
viduals with the ε32 genotype than the ε33
genotype in both parents and children.
Surprisingly, we found the greatest similarity of
genotype-specific effects on trait means in female
children and male parents.
Second, we compared the influence of variation
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Fig. 2. (A) Correlation diagrams showing the bivariate correlations between traits where r r r" 0.3 for each
APOE genotype in males. TC is the sum of the 36 pairwise correlations. (B) Difference correlation diagrams
showing the statistically significant differences between genotype-specific bivariate correlations.
in APOE genotype on the trait variances in each
generation. Children differed more from parents
with respect to inferences about the homogeneity
of genotype-specific interindividual variances
(Fig. 3, second column) than homogeneity of
trait means. In parents, 11 of 36 tests of
homogeneity of variance were rejected with p%
0.05, with eight of those 11 significant results
observed in females. In children, only three of 36
tests were significant, all observed in males. The
most striking comparison of the influence of
APOE on the variances in children with adults
was with respect to Total-C. In both female and
male children, the variance of Total-C among
individuals with the ε32 or the ε43 genotypes was
smaller than for those with the ε33 genotype,
though the differences were not statistically
significant. However, in parents the APOE
genotype had a very strong influence on the
variance of Total-C with the variance among
those with the ε32 or the ε43 genotype being
significantly greater than ε33 and more than
twice the magnitude observed in children.
Third, we present in Figure 3 the influence of
variation in the APOE gene for each gender-
generation stratum on correlations. Overall, the
lipid and apolipoprotein traits were more highly
correlated in parents (TC¯ 13.402, 12.055, and
13.042 for ε32, ε33, and ε43 females, respectively
and TC¯ 13.567, 12.753, and 13.894 for ε32, ε33,
and ε43 males, respectively) than they were in
the children (TC¯ 10.832, 10.095, and 14.156 for
ε32, ε33, and ε43 females, respectively and TC¯
11.421, 11.326, and 12.260 for ε32, ε33, and ε43
males, respectively). In parents there was a very
strong negative correlation between lnTrig and
HDL-C and very strong positive correlations
between lnTrig and Total-C and Apo B. These
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Fig. 3. Summary of significant results of the tests of homogeneity of means, variances, and correlations in
children (A) and parents (B). The statistics for the ε32 and ε43 genotypes are indicated by W if they are
significantly higher and X if they are significantly lower than the reference ε33 genotype.
three correlations were consistent across APOE
genotypes but they were much weaker in female
and male children than in the parents. The
significant differences in pairwise correlations
among genotypes were also very different in
parents and children. There was more genotype-
specific heterogeneity of correlation in male
children than in male parents. None of the
gender- and genotype-specific significant
differences in correlation were observed in both
generations.
Influence of APOE genotype on multivariate
measures in children and parents
A visualization of the total impact of variation
in APOE genotype on the means, variances, and
correlations in children and parents is provided
through multivariate graphs in Figures 4 and 5
for females and males, respectively. These multi-
variate graphs combine information from each of
the nine generation-, gender-, and genotype-
specific means and variances, as well as on the
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Fig. 4. Multivariate profile of female children and parents. See text for description.
combined contribution of the traits to multi-
variate measures of the mean and variance
vectors and the correlation matrix. To remove
scale differences between traits, the pooled data
from all genotype-gender-generation strata was
adjusted to a standard normal scale (mean¯ 0.0
and ..¯ 1.0). This re-scaling also permits
direct comparisons of the deviations of each of
the 12 generation-, gender-, and genotype-strata
from the reference established by the pooled
data. The six multivariate stars (parents and
children for each of the three genotypes) in
Figures 4 and 5 depict the mean (upper half) and
variance (lower half) values for each re-scaled
trait, which are given in Tables A 1 and A 2 in
the Appendix. The length of each ray is pro-
portional to the deviation of each generation-,
gender-, and genotype-specific mean and vari-
ance from the minimum scaled mean and vari-
ance for all traits. The orientation of each ray
indicates the corresponding trait, as shown in the
upper left-hand corner of each Figure. Stars
corresponding to parents are indicated by a solid
drop line and those for children by a dashed drop
line.
The location of the centre of each star in the
three dimensional graph shows the Euclidean
distance of the means from the origin, total
variance, and total correlation for each genotype
in females and males. The Euclidean distance is
the straight line distance between two points in
space. It is used here to measure the distance of
the point defined by the vector of trait means
from the origin in nine-dimensional space. It is
computed by taking the square root of the sum of
the nine squared re-scaled means (details can be
found in Reilly et al. 1991). The total variance is
computed by summing the variances of the re-
scaled data for all traits across the nine traits.
The method for calculating the total correlation
is presented above in the Statistical methods
section. Estimates of the total correlation are not
changed by the re-scaling.
In females (Fig. 4), the Euclidean distances of
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Fig. 5. Multivariate profile of male children and parents. See text for description.
the means in the children were approximately
equal, while in parents it was smallest in ε33
females, and largest in ε32 females. The
Euclidean distances of the means in children
were intermediate between the ε33 and ε32
Euclidean distances of the means in parents.
Similar patterns were observed within
generations with respect to the total variance.
However, female parents had a greater total
variance than female children for each genotype.
The shapes of the stars differed both in size and
shape among APOE genotypes and generations.
The total correlations in children and parents
were discussed in the preceding sections.
In males (Fig. 5), the generation-specific
Euclidean distances were smallest in the ε33
strata and largest in the ε32 strata, and the
genotype-specific distances were smaller in chil-
dren than parents. As in females, the total
variances were uniformly greater in parents than
children. The ε43 male children had the smallest
total variance and the ε32 male children had the
largest total variance, and the ε33 and ε43 male
parents had similar total variances but sub-
stantially smaller than the total variance of the
ε32 male parents.
There are several general features of these
graphs that summarize the impact of generation,
gender, and genotype on scale, variability and
co-variability. First, while the females tended to
cluster more by the Euclidean distance of the
means and vary more by their total variances
and total correlations, males tended to cluster
more by their total variances and total corre-
lations and vary more by their Euclidean
distances. Second, we call attention to the
observation that the shapes of the portion of the
stars summarizing means tended to resemble the
portion summarizing the variances, reflecting
the positively correlated nature of the means and
variances. Third, we found an unexpected posi-
tive correlation between the total variance and
the total correlation, illustrated by the location
of 11 of the 12 stars above the diagonal line.
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Since the correlation is computed by dividing the
covariance by the product of the standard
deviation for each trait, if the covariance remains
constant the correlation will be reduced as the
variance for each trait increases. The observed
positive correlation must result as a consequence
of the covariances between traits generally
increasing more rapidly than their variances.

Because the natural history of CHD begins
relatively early in life (Hixson, 1991; McGill et al.
1997), much attention has been devoted to the
study of CHD risk factors in children. In addition
to traditional CHD risk factors, a better under-
standing of the role that common genetic
variation plays in the early pathogenesis can
offer insights into the biology of the natural
history of disease, may suggest improved treat-
ment strategies, and promises more accurate
identification of subgroups within the population
at large that are at increased risk for developing
heart disease. In this paper, we have evaluated
the influence of variation in one gene, APOE, on
the univariate distributions of nine participants
in plasma lipoprotein metabolism and the
bivariate correlations between them in children,
and compared these results to similar studies
conducted previously in parents from the same
sample of pedigrees. We found that the influence
of each of the three common APOE genotypes on
the trait means and the intra-genotypic
variances and correlations was gender and gen-
eration specific. We discuss below four impli-
cations of these findings for our understanding of
the etiology of interindividual variation in quan-
titative risk factor variation, and for the
utilization of genetic information to predict
interindividual variation in risk of CHD.
First, the pleiotropic effects of each APOE
genotype on the multivariate vector of nine trait
means are dependent on context indexed by
gender and age. Our study of children further
documents that the pleiotropic influences of
genotypic variation on interindividual variation
in the levels of quantitative traits that are
plasma measures of lipid metabolism are de-
pendent on context defined by gender. Combined
with the results of our previous studies of adults
from the same sample of pedigrees (Reilly et al.
1991) it is clear that the influence of genetic
variation on levels of plasma measures of the
lipid metabolism should be studied separately in
females and males. The heterogeneity of
inferences about APOE genotype means between
children and adults in females and males
establishes that age is also an index of variation
in agents that alter genotype effects. Variability
in the contribution of the nine traits to the height
of the centroid that is portrayed by the varia-
bility in the shape of the upper halves of the
multivariate stars in Figures 4 and 5 represents
variation in the pleiotropic effects of each
genotype on the nine traits among the twelve
generation-, gender-, and genotype-strata. The
only exception to the general observation of
context dependency of genotype effects is the
consistent statistically significant differences
among genotypes for the average level of lnApo
E in both genders in children and parents. These
findings further validate the concern by Sing et
al. (1996) that genotype-phenotype models for
quantitative traits must accommodate a mix of
invariant genotypic effects and genotypic effects
that are dependent on interindividual variation
in the contemporary ecological context, the
history of exposures to environmental agents
and the epigenetic phenomena that operate
throughout the life cycle. Evidence that effects of
the APOE genotypes have invariant average
effects only on the level of the primary gene
product that is physiologically closer to the
APOE gene, and hence less susceptible to the
influences of exposure to external environmental
variations, lends biological credence to the need
for more realistic statistical models of genotype-
phenotype relationships for quantitative CHD
risk factors than have been traditionally
employed in genetic epidemiological studies.
One other study has investigated the influence
of APOE on plasma lipid and apolipoprotein
means in female and male children separately. In
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a study of 1544 Finnish children, ages 3 to 18,
Porkka et al. (1994) found significant variation in
Total-C among four APOE genotypes (ε32, ε33,
ε43, and ε44) in both females and males. We
found statistically significant differences among
APOE genotypes in males only and, although not
statistically significant, the ranks of the genotype
means were the same in females as in males. They
also observed the same rankings among geno-
types of plasma lnTrig in females as reported
here, though the differences were not statistically
significant. Given the differences between these
two studies in the characteristics of the popu-
lations considered, the sampling design, and the
statistical methods that were used, the gender-
specific influence of variation in the APOE
genotype on trait means in children was re-
markably consistent.
The primary influence of the APOE protein
product on lipid metabolism involves intestinal
cholesterol absorption, hepatic clearance of tri-
glyceride rich chylomicron and VLDL particles,
and metabolism of LDL particles. Adults
carrying the ε2 allele tend to absorb cholesterol
from the intestine and clear chylomicron and
VLDL particles more slowly than ε33 individuals
and catabolize LDL particles more quickly
(Mahley, 1988). Adults carrying the ε4 allele tend
to have higher rates of cholesterol absorption
and chylomicron and VLDL clearance and lower
rates of LDL catabolism than ε33 individuals
(see Davignon et al. 1988; Davignon, 1993). In
our study of children, a statistically significant
influence of variation in the APOE gene on
chylomicron and VLDL related trait means was
only observed in females, and the influence on
LDL related trait means was only observed in
males. Female children with the ε32 genotype
had significantly higher chylomicron and VLDL
related trait means. Paradoxically, female chil-
dren with the ε43 genotype also had significantly
increased levels of lnTrig. How these funda-
mental physiological processes are influenced by
agents that are indexed by gender and age is the
major hurdle in establishing biologically mean-
ingful interpretations of the statistical evidence
for context dependent genotype effects. In this
regard, efforts to develop an ability to identify
and measure the interacting agents and the
epigenetic processes in population based study
designs, as easily and accurately as it is possible
to measure genotypes, are long overdue.
The existence of context dependent genotype
effects on mean levels brings into question the
routine statistical adjustment of quantitative
risk factors for gender and age variation before
estimating genotype effects. Inferences from
genotype means about trait levels estimated
from adjusted data may not be appropriate for
any age or either gender. Furthermore, when
there are context dependent genotype effects,
the evaluation of replication of the estimates of
genotype effects across studies to establish
invariant biological truths, or the estimation of
genotypic effects from a meta-analysis of pooled
data, can lead to inappropriate inferences about
the utility of genetic information for most
individuals, families, age groups, or populations.
Second, the intragenotypic variance of each
trait and correlation between traits is dependent
on context defined by genotype, gender, and age.
Most studies of the pleiotropic effects of geno-
typic variation assume homogeneity of intra-
genotypic variability of each trait and co-
variability between the members of the set of
traits of interest and hence ignore the possibility
of estimating, or testing hypotheses about, the
influence of genetic variation on phenotypic
plasticity (Bradshaw, 1965; Schlichting &
Pigliucci, 1998). Our gender and trait specific
findings in children support the generality of the
argument that the gender dependent influences
of genetic variation on the characteristics of a
complex system, such as lipid metabolism, is not
solely limited to average levels of the component
traits. The general observation that there is
greater heterogeneity of the intragenotypic trait
variance among APOE genotypes in parents
than children, and that trait variances and
correlations are greater in parents than in
children for both genders, clearly documents a
genotype, gender, and generation influence on
intragenotypic phenotypic plasticity. These
results argue that APOE genotypes vary in their
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biological influence on the range of phenotypic
expression of each component trait and the
coherence, or biological connectedness, between
traits. The means, variances, and correlations
that are characteristic of each genotype are
measures of the ‘norm of reaction’ or ‘adaptive
response’ to variation in unmeasured genetic and
environmental agents.
Heterogeneity in the adaptive response may
be a consequence of genotype by environment
interaction, different interacting agents, or
alternative forms of the same interacting agents
being non-randomly distributed among the
different gender and generation strata. Studies
that consider interaction effects of the APOE
genotypes with other genes and the effects of
exposures to environmental agents are required.
Relatively few studies have addressed the role of
gene-gene interactions on measures of lipid
metabolism. However, numerous studies have
documented interactions in adults between
APOE genotype effects and effects of various
environmental agents, including smoking
(Kaprio et al. 1989), diet (Ma$ ntta$ ri et al. 1991;
Cobb et al. 1992), exercise (Taimela et al. 1996),
measures of body size (Reilly et al. 1992), drug
treatment (Nestruck et al. 1987; Carmena et al.
1993), and age (Jarvik et al. 1997). The observed
heterogeneity of variance for seven of nine traits
and larger correlations in parents is consistent
with an increasing role of environmental agents
with age. However, it is unlikely that the same
variations in any one factor or the same factors
are involved in interactions with APOE in all
gender and age strata.
Also, a history of interactions with environ-
mental factors may influence contemporary
variability and covariability of traits. The chil-
dren studied have been exposed to a much more
limited number of environmental agents over a
shorter period of time than their parents, who
are on average 29 years older, providing fewer
opportunities for interactions to have occurred.
Alternatively, if variation in a particular en-
vironmental agent is generation-specific, such as
particular dietary components, quality of medi-
cal care, or type of environmental pollutants,
there may be genotype-specific influences that
remain unique to each generation. We might
expect the genotype-specific differences in
variances and correlations observed in what is
currently the child generation to begin to
resemble the parent generation as they age if the
responsible environmental exposures are com-
mon to the aging process, such as sexual
maturation, child bearing, and changes in physi-
cal activity.
Another etiological explanation for the het-
erogeneity of intra-genotypic variances and
correlations among generation, gender, and
genotype strata is possible. There may be
combinations of genotypes in the genes that
interact with APOE that occur in the parents
that were not reproduced in the children, par-
ticularly if the samples being studied represent a
recently admixed population.
Third, the context dependent penetrance func-
tion for each APOE genotype foretells complex
biological relationships between genomic vari-
ation and variation in measures of lipid metab-
olism. The complexity of biological relationships
between genotype and phenotype have been
recognized for nearly 100 years (Garrod, 1908;
Fisher, 1918; Wright, 1923). Most of the molecu-
lar and statistical studies in biomedicine over the
past four decades have either not asked about
the nature of these relationships, or have made
oversimplified assumptions about them that
severely limit biologically meaningful inferences.
It has been established from statistical studies of
the sort reported here that the relationships
between genome variations and phenotypic
variations are not one-to-one. The digital geno-
type information at the genome level influences
both the quality and quantity of the agents at
the intermediate biochemical level which interact
with the internal physiological, and external
environmental, agents toproduce emergentquali-
tative properties that are probability functions
of the genetic, biochemical, and environmental
information in the hierarchy. It is imperative to
conclude that neither genes nor environments
are the causes of phenotypic variation
(Lewontin, 1992).
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Realistic models for the statistical relation-
ships between genome and phenome that take
these complexities into account have yet to be
devised. Such models will include a mix of
invariant phenotypic properties that do not
depend on context (e.g. correlation between Apo
B and Total-C), context dependent phenotypic
effects that depend on genotype (e.g. higher
lnTrig in the ε43) and genotype effects that
depend on context (e.g. higher correlation be-
tween Apo AI and HDL-C in the ε33 than ε32 in
children but not parents). Such a model must
also take into account the increasing importance
of context on the influence of phenotypic vari-
ation as the biological distance between the
genome and each trait in the hierarchical
organization of a complex system like lipid
metabolism increases.
Fourth, the implications of genotype, gender,
and age dependency of the distribution of
quantitative risk factors are central to the
utilization of genomic information for under-
standing the biology of health, selecting
therapies for disease, and predicting those sub-
groups at risk. There is a tendency among
geneticists and non-geneticists alike to make
very general statements about the influence of
particular genetic variants based on few studies
with little regard to the contexts associated with
the referenced studies. This leads to the mistaken
understanding that a genotype has an intrinsic
invariant biological effect. The work reported
here and elsewhere suggests that for complex
traits, such as quantitative CHD risk factors, the
effect of a genotype is dependent on the context
in which the genotype is embedded. Only after
genotypic influences are studied over a range of
contexts (the norm of reaction for each genotype)
can we develop conceptual models to describe the
biology of health. These models can subsequently
be applied to predict those population subgroups
that are at increased risk of disease, as well as aid
in the selection of more efficacious disease
treatment strategies.
In summary, our research demonstrates that
variation in the APOE gene influences the
distributions of each of nine measures of plasma
lipoprotein metabolism, as well as the bivariate
relationships between them. Moreover, our study
establishes that the influence of variation in the
APOE gene is characterized by a combination of
a few invariant effects that are consistent
regardless of gender and generation context
(variation in mean levels of lnApo E), and many
context dependent properties, wherein the
influence of variation in the APOE gene must be
considered separately for each gender and gen-
eration context. Our work to estimate the norm
of reaction associated with each of the APOE
genotypes suggests the complexity that we can
expect in the relationships between genome
variations and variations in measures of health
in the population at large.
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Table A 1. Means and variances in female children and parents after adjustment of data to a N(0,1)
scale
Children Parents
Adjusted values ε32 ε33 ε43 ε32 ε33 ε43
Means
lnApo E 0.63 0.04 ®0.60 0.55 0.21 ®0.52
Apo CII 0.08 ®0.42 ®0.46 0.28 ®0.15 ®0.29
Apo CIII 0.27 ®0.37 ®0.30 0.98 ®0.05 ®0.06
lnTrig 0.07 ®0.47 ®0.23 0.21 ®0.10 ®0.10
Apo AI ®0.14 ®0.21 ®0.19 0.52 0.44 0.51
Apo AII ®0.07 ®0.22 0.01 0.02 0.13 0.25
HDL-C 0.27 0.17 0.00 0.33 0.38 0.40
Apo B ®0.41 ®0.43 ®0.29 ®0.02 0.13 0.31
Total-C ®0.66 ®0.57 ®0.46 0.02 0.27 0.41
Euclidean distance 1.09 1.08 1.02 1.33 0.72 1.05
Variances
lnApo E 1.38 0.87 0.60 0.95 0.72 0.75
Apo CII 0.45 0.48 0.61 1.50 0.84 1.10
Apo CIII 0.62 0.61 0.59 3.02 0.87 0.73
lnTrig 0.50 0.58 0.62 1.60 0.84 1.03
Apo AI 0.54 0.91 1.24 1.07 0.98 1.19
Apo AII 0.87 0.89 0.98 1.05 0.60 1.16
HDL-C 0.95 0.84 0.65 1.69 1.15 1.04
Apo B 0.68 0.67 0.49 0.72 0.81 1.31
Total-C 0.26 0.49 0.47 1.02 0.63 1.00
Total variance 6.26 6.32 6.25 12.62 7.44 9.29
Table A 2. Means and variances in male children and parents after adjustment of data to a N(0,1)
scale
Children Parents
Adjusted values ε32 ε33 ε43 ε32 ε33 ε43
Means
lnApo E 0.46 ®0.04 ®0.79 0.97 0.85 0.87
Apo CII 0.02 ®0.12 ®0.03 1.22 0.92 1.05
Apo CIII ®0.21 ®0.26 ®0.17 1.74 0.93 0.85
lnTrig ®0.09 ®0.35 ®0.23 1.27 0.92 1.02
Apo AI ®0.50 ®0.24 ®0.23 1.03 0.99 1.09
Apo AII ®0.48 ®0.25 ®0.01 1.03 0.78 1.08
HDL-C ®0.10 0.06 ®0.05 1.30 1.07 1.02
Apo B ®0.65 ®0.51 ®0.28 0.85 0.81 1.14
Total-C ®0.90 ®0.53 ®0.39 1.01 0.80 1.00
Euclidean distance 1.41 0.93 1.00 2.23 1.25 1.58
Variances
lnApo E 0.80 0.90 0.87 1.47 0.85 0.87
Apo CII 1.28 0.64 0.52 1.37 1.25 1.01
Apo CIII 0.62 0.66 0.50 1.31 1.21 1.17
lnTrig 1.08 0.58 0.72 1.07 1.02 1.00
Apo AI 0.77 0.89 0.71 0.67 0.87 0.84
Apo AII 1.20 1.09 1.24 0.95 1.06 0.97
HDL-C 0.61 1.08 0.60 0.42 0.72 0.69
Apo B 0.50 0.48 0.56 0.82 1.08 1.40
Total-C 0.44 0.61 0.58 1.38 0.80 1.41
Total variance 7.29 6.93 6.30 9.46 8.85 9.35
